For Specialized Pharmacy and Health Care Legal Services Call (720)222-1276 • Baer Law provides services to all of the United States
Baer Law
25521 E. Smoky Hill Road
Suite #120, Aurora, CO 80016
720.222.1276
About Baer Law
John brings over twenty-five combined years of experience as a pharmacist and attorney to the Baer Law Firm LLC. John's personal goal since finishing law school was to incorporate both his experiences as a clinical pharmacist and an attorney into his own, successful law practice. After obtaining his undergraduate and his Doctorate of Pharmacy (PharmD) degrees from the University of Arizona, John relocated to Colorado. He continued to work as a clinical hospital pharmacist while attending law school and obtained his Juris Doctorate (JD) at the University of Denver College of Law.
Our Legal Services
We are uniquely positioned to understand the complex needs of our diverse clients.
Pharmacy Law
As an expert in the field, Baer Law covers a variety of Pharmaceutical Law services ranging from Federal & State Regulatory Issues to FDA Compliance and Drug Compounding.
Health Care Law
Baer Law focuses on a variety of health care law services ranging from Telemedicine / Telepharmacy and HIPAA Compliance to Professional Board Actions.
Client Testimonial
The Drug Quality and Security Act: Compounding Guidance
In November 2013, President Obama signed the Drug Quality and Security Act (DQSA), a law that aims to address and improve the safety of the United States pharmaceutical supply and contains updates to the oversight systems for pharmaceutical compounding. In December 2013, the United States Food and Drug Administration (FDA) released (for public comment) six…
FDA Releases Draft Guidance on Section 503B Fees for Outsourcing Facilities.
Section 503B of the Federal Food, Drug and Cosmetic Act (FDCA) created a new Food and Drug Administration (FDA) regulated entity called an ‘outsourcing facility.’ As discussed previously on the Baer Law Blog, a registered outsourcing facility is permitted to compound sterile drugs for human use with or without a prescription after voluntarily registering with…
FDA Preparing a List of Bulk Drug Substances for Compound Drug Products
The Food and Drug Administration (FDA) is preparing a list of bulk drug substances that outsourcing facilities may use to compound drug products in accordance with Section 503B of the Food, Drug and Cosmetic Act (FDC Act). Requests for electronic and written nominations ended in early March 2014. Section 503B of the FDC Act defines…